BridgeBio Pharma, Inc. (BBIO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Cash flow
All numbers in thousandsBreakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-538,262
-643,202
-481,183
-562,539
-448,724
-
Depreciation & amortisation
6,457
6,494
6,771
5,843
1,456
-
Stock-based compensation
103,860
108,710
91,559
99,505
58,459
-
Change in working capital
-188,340
5,057
28,079
-4,396
14,934
-
Accounts payable
653
2,780
-349
2,833
-735
-
Other working capital
-605,721
-529,026
-425,815
-546,180
-407,232
-
Other non-cash items
21,647
23,327
-90,025
18,498
32,791
-
Net cash provided by operating activities
-602,935
-527,720
-419,494
-497,934
-399,714
-
Cash flows from investing activities
Investments in property, plant and equipment
-2,786
-1,306
-6,321
-48,246
-7,518
-
Acquisitions, net
-
-
-
-
0
0
Purchases of investments
-154,456
-137,264
-193,055
-643,275
-287,852
-
Sales/maturities of investments
196,048
193,106
532,523
477,041
249,137
-
Other investing activities
-
-503
120,000
13,654
-6,760
-
Net cash used for investing activities
64,488
54,033
453,147
-200,826
-52,993
-
Cash flows from financing activities
Debt repayment
-473,417
0
-20,486
-124,119
0
-
Common stock issued
622,048
449,810
4,852
0
0
-
Common stock repurchased
-9,304
-6,880
-1,561
-204,746
-75,714
-
Dividends paid
-
-
-
-
0
-997
Other financing activities
-18,798
-801
837
-97,654
8,055
-
Net cash used provided by (used for) financing activities
580,834
451,535
-13,134
736,446
447,189
-
Net change in cash
42,387
-22,152
20,519
37,686
-5,518
-
Cash at beginning of period
435,109
416,884
396,365
358,679
364,197
-
Cash at end of period
477,496
394,732
416,884
396,365
358,679
-
Free cash flow
Operating cash flow
-602,935
-527,720
-419,494
-497,934
-399,714
-
Capital expenditure
-2,786
-1,306
-6,321
-48,246
-7,518
-
Free cash flow
-605,721
-529,026
-425,815
-546,180
-407,232
-
© 2024 Yahoo. All rights reserved.